dromlakhani/md2skill/ata-ppgl-genetic-variant-treatment-algorithm
Claude Code and agent skill by dromlakhani/md2skill
- community
Checking that the SKILL.md file is still in the repository.
This skill selects a treatment algorithm for pheochromocytoma and paraganglioma based on identified germline pathogenic variants, enabling personalized management per syndrome-specific guidelines. It is triggered when a clinician identifies RET, VHL, NF1, or SDHx pathogenic variants and asks how genetic results should change management.
Install
npx vskill@latest install dromlakhani/md2skill/ata-ppgl-genetic-variant-treatment-algorithmSKILL.md
The same SKILL.md was published earlier as dromlakhani/md2skill/ata-ppgl-genetic-variant-treatment-algorithm.
Select treatment algorithm based on genetic pathogenic variants in pheochromocytoma and paraganglioma
STEP 1 — Gather Information
Collect germline genetic test results (RET, VHL, NF1, SDHx) and clinical data: number of lesions, adrenal vs. extra-adrenal location, presence of metastasis, and syndromic features (e.g., medullary thyroid carcinoma, hemangioblastoma, café-au-lait spots).
STEP 2 — Rule In / Rule Out
Is the pathogenic variant in RET, VHL, or NF1? If yes, proceed to syndrome-specific pathway; if no, proceed to SDHx pathway.
STEP 3 — Classify or Stratify
For RET/VHL/NF1: classify by syndrome and follow respective guideline-recommended surveillance (e.g., MEN2, VHL, NF1). For SDHx: stratify by clinical characteristics—multiple/extra-adrenal lesions or high metastasis risk versus solitary adrenal lesion with low risk.
STEP 4 — Decide
For RET/VHL/NF1: implement syndrome-specific surveillance (e.g., annual plasma metanephrines, neck ultrasound, abdominal MRI) and consider prophylactic surgery per syndrome guidelines. For SDHx: if multiple/extra-adrenal lesions or high metastasis risk, obtain intensified imaging (68Ga-DOTATATE PET/MRI) and discuss PRRT/temozolomide/sunitinib (off-label); if low risk, standard biochemical and imaging follow-up every 1–2 years.
Clinical Guardrails / Mimics / Pitfalls
Do not neglect surveillance for SDHx carriers even if initial imaging is negative; avoid invasive procedures based solely on variant without clinical correlation; remember to offer genetic testing and counseling to first-degree relatives; do not assume all SDHx variants confer equal metastasis risk—correlate with phenotype.
Concrete Clinical Example
A 34-year-old with left adrenal pheochromocytoma is found to have a RET codon 634 pathogenic variant. Management follows MEN2 guidelines: annual plasma metanephrines, neck ultrasound for medullary thyroid carcinoma, and discussion of prophylactic thyroidectomy; abdominal MRI biennially to monitor for bilateral or extra-adrenal lesions.
Source: Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025, Japan Endocrine Society, 2025, doi:10.1507/endocrj.EJ25-0165
Security
- Security scanPassed, 90 of 100Pattern checks on the skill's files.
- Model reviewPassed
Quality evaluation
- Task evaluationNot runNo evaluation yet. Run one in Skill Studio.
Source
- SKILL.md in the repositoryCheckingskills/endocrinology/phaeochromocytoma/ata-ppgl-genetic-variant-treatment-algorithm/SKILL.md
Popularity
- Repository stars
- 12
- Repository forks
- 1
- 7-day trend score
- 18
Stars and forks are for the whole GitHub repository, not this skill alone. Not refreshed yet.
Works with
Any agent vskill installs to: 56 targets in all. These 39 have a page on this site.
- Claude Code
- Cursor
- GitHub Copilot
- Windsurf
- Codex
- Gemini CLI
- Cline
- Amp
- Roo Code
- Goose
- Continue
- Kilo Code
- Junie
- Trae
- OpenHands
- Qwen Code
- AI Agent
- Tabnine Chat
- Sourcegraph Cody
- Amazon Q
- Firebase Genkit
- Sweep
- Devin
- Phind
- Mentat
- Claude Desktop
- Aider
- GPT Pilot
- Plandex
- bolt.new
- v0
- Replit Agent
- Anse
- TypingMind
- BetterChatGPT
- LibreChat
- Warp AI
- Pieces
- Fig AI
Embed badge
[](https://verified-skill.com/skills/dromlakhani/md2skill/ata-ppgl-genetic-variant-treatment-algorithm)